Conference
CA-125 response as a marker of clinical benefit in patients with recurrent ovarian cancer treated with gemcitabine and sorafenib-A trial of the PMH Phase II Consortium
Authors
Welch S; Hirte H; Elit L; Schilder RJ; Pond G; Kovacs J; Wright J; Oza AM
Volume
25
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2007
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X